The Global Pancreatic Cancer Therapeutics Market Size was valued at USD 3,582 Million in 2021 and is predicted to be worth USD 6,575 Million by 2030, with a CAGR of 7.2% from 2022 to 2030.

The increasing incidence and prevalence of pancreatic cancer, as well as advances in cell genetics, biomedical research, and diagnostic technologies, all contribute to the pancreatic cancer therapeutics market growth. According to the pancreatic cancer therapeutics industry analysis, the market is expected to grow significantly over the projected period due to rising R&D investments, favorable reimbursement circumstances, and the introduction of new products and services. Similarly, increased obesity, consumption of alcohol, and smoking addiction rates are predicted to drive the pancreatic cancer therapeutics market size. Pancreatic cancer is usually detected later and unintentional weight loss, persistent loss of appetite, etc. are some symptoms seen among patients. Surgery, radiation therapy, chemotherapy, targeted therapy and immunotherapy are smog treatments available for patients depending upon their condition.

Global Pancreatic Cancer Therapeutics Market DRO’s

Market Drivers

• Growing incidence of cancer across the globe
• Increasing healthcare infrastructure projects
• The rising geriatric population
• Rising governmental and non-governmental initiatives to raise awareness

Market Restraints

• Rising costs associated with the treatment
• A scarcity of skilled professionals and a lack of healthcare infrastructure in emerging economies

Market Opportunity

• Increase in the number of R&D activities in the healthcare sectors

Report Coverage

Pancreatic Cancer Therapeutics Market Dynamics

Pancreatic cancer is a growing concern among consumers across the globe. According to American Cancer Society, about 60,430 people (31,950 men and 28,480 women) are expected to be diagnosed with pancreatic cancer. The rate of new cases of pancreatic cancer was 13.2 per 100,000 men and women per year. Investment by major players for development of new solutions in order to enhance patient care is increasing. In addition, high investment by the government on development of healthcare infrastructure with the focus to enhance the patient experience and increase the care ratio these factors are expected to augment the growth of pancreatic cancer therapeutics market value. In 2021, Lantern Pharma, a global biopharmaceutical company in collaboration with Fox Chase Cancer Center published the data from successful use of LP-184 for rapid pancreatic tumor shrinkage, by over 90%, in in-vivo mouse models in 8 weeks. Enterprises are focused on new drug development with the increasing clinical trials, new drug approvals and introduction of new surgical solutions are impact the growth of target market.

Enterprises are focused on shifting their production unit to developing countries due to easy availability of raw material and low cost labor. In addition, availability of favorable business policies by the government and players inclination towards strategic partnership are factors expected to boost the market growth. Factors such as high cost associated to R&D activities, time consuming process and stringent government regulations related to product approval are expected to hamper the growth of global pancreatic cancer therapeutics market. In addition, lack of developed infrastructure in developing countries is expected to challenge the growth of target market. However, rise in investment by major players, increasing government spending on development of healthcare infrastructure and new introduction of new solutions are factors expected to create new opportunities for players operating in the pancreatic cancer therapeutics market over the forecast period. In addition, increasing PPP for R&D activities is expected to support the revenue transaction of the target market.

Pancreatic Cancer Therapeutics Market Segmentation

The global pancreatic cancer therapeutics market is segmented into treatment type and end use. The treatment type segment is bifurcated into surgery, chemotherapy, radiation therapy, and others. Among treatment type the surgery segment is expected to account for noticeable revenue share in the global market. The end use segment is divided into hospitals, clinics, research institutes, and others.

Market by Treatment Type

• Surgery
• Chemotherapy
• Radiation Therapy
• Others

Market by End-Use

• Hospitals
• Clinics
• Research Institutes
• Others

Pancreatic Cancer Therapeutics Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Latin America

• Mexico
• Brazil
• Rest of Latin America

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

The Middle East & Africa (MEA)

• Gulf Cooperation Council (GCC)
• South Africa
• Rest of the Middle East & Africa